Stuart

Shakespeare's environmentalism: how his plays explore the same ecological issues we face today

Retrieved on: 
Friday, April 21, 2023

In fact, the common but misleading phrase “industrial revolution” masks the long history of resource extraction and ecological degradation in the British Isles stretching back at least to the arrival of the tin-hungry Romans.

Key Points: 
  • In fact, the common but misleading phrase “industrial revolution” masks the long history of resource extraction and ecological degradation in the British Isles stretching back at least to the arrival of the tin-hungry Romans.
  • Renaissance England was reeling from the effects of all these problems.

King and countryside

    • When King James became his patron in 1603, Shakespeare was tasked with writing plays to entertain a keen outdoorsman and hunter who was as much preoccupied with the material state of the British countryside as with matters of state.
    • No wonder, then, the Shakespearean stage encompasses a remarkable variety of landscapes and features an abundance of animal imagery to rival the royal menagerie – basically King James’s private zoo – and compensate for England’s dwindling numbers of wild game.
    • These articles mark the 400th anniversary of the publication of the First Folio, the first collected edition of William Shakespeare’s plays.

Enduring environmental issues

    • Shakespeare adapted the story from a writer whose father had proposed the existence of a flooded land-bridge linking Britain to the continent (now known as Doggerland.
    • While the shipwrecked king refutes claims to rule the unruly seas, the costumes donned by Shakespeare’s actors would have told a different story.
    • Hermione acts like her namesake when she exclaims she too would rather die than stain her name as an adulteress.
    • In inserting these environmental issues into his plays, Shakespeare forced his audience to reflect on the political, moral, and spiritual implications of early modern England’s growing power to transform the natural world.

The Marygold Companies Appoints Two New Board Members

Retrieved on: 
Monday, April 17, 2023

The Marygold Companies, Inc. (“TMC,” or the “Company”) (NYSE American: MGLD), today announced the appointments of James S. Alexander and Stuart Crumbaugh to its board of directors.

Key Points: 
  • The Marygold Companies, Inc. (“TMC,” or the “Company”) (NYSE American: MGLD), today announced the appointments of James S. Alexander and Stuart Crumbaugh to its board of directors.
  • View the full release here: https://www.businesswire.com/news/home/20230417005084/en/
    Mr. Alexander fills a vacancy on the Company’s board as an independent director.
  • Mr. Crumbaugh succeeds management director Kathryn Rooney, who departs from her board position upon her appointment to the board of directors of United States Commodity Funds, LLC (“USCF LLC”), the Company’s indirect subsidiary.
  • “We welcome James to our company and know that he and Stuart will be strong board contributors, guiding the Company’s future course.

Stuart Peltz, Ph.D., Rare Disease Pioneer, to Retire as Chief Executive Officer of PTC Therapeutics

Retrieved on: 
Friday, March 24, 2023

SOUTH PLAINFIELD, N.J., March 24, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT). Stuart Peltz, Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years. Dr. Peltz has led PTC Therapeutics as its CEO since its founding in 1998 and pioneered the field of RNA-directed drug development. Under his leadership, PTC has grown from a research organization with expertise in the control of RNA processes to a publicly traded, integrated, global biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for the treatment of neurological and neuromuscular disorders, metabolic disorders, and cancer.

Key Points: 
  • Stuart Peltz, Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years.
  • Dr. Peltz has led PTC Therapeutics as its CEO since its founding in 1998 and pioneered the field of RNA-directed drug development.
  • What Stuart and the team have achieved in 25 years is extraordinary," said Michael Schmertzler, Chairman of the Board of Directors.
  • Matthew Klein, M.D., M.S., F.A.C.S., current Chief Operating Officer, has been named the company's CEO and will join the Board of Directors.

Intel Appoints Stuart Pann to Lead Intel Foundry Services

Retrieved on: 
Tuesday, March 21, 2023

Intel Corporation today announced the appointment of Stuart Pann as senior vice president and general manager of Intel Foundry Services (IFS), Intel’s commercial foundry business.

Key Points: 
  • Intel Corporation today announced the appointment of Stuart Pann as senior vice president and general manager of Intel Foundry Services (IFS), Intel’s commercial foundry business.
  • View the full release here: https://www.businesswire.com/news/home/20230321005442/en/
    Stuart Pann is senior vice president and general manager of Intel Foundry Services (IFS), Intel’s commercial foundry business.
  • “Intel Foundry Services is a critical pillar of our IDM 2.0 strategy, and it’s been exciting to watch it grow from an idea to an operating business with a world-class IP portfolio and significant customers in less than two years,” Pann said.
  • Pann replaces Dr. Randhir Thakur, the inaugural general manager of Intel Foundry Services, who stepped down from the role in November 2022 and will depart Intel at the end of March to start a new chapter outside the company.

Eiseman Construction Owner Joins Michener Art Museum Board of Directors

Retrieved on: 
Monday, March 20, 2023

DOYLESTOWN, Pa., March 20, 2023 /PRNewswire-PRWeb/ -- Eiseman Construction is pleased to announce that owner Melissa Eiseman has joined the board of directors of the James A. Michener Art Museum. Based in Doylestown, the Michener Museum showcases American art with a particular focus on Bucks County artists.

Key Points: 
  • DOYLESTOWN, Pa., March 20, 2023 /PRNewswire-PRWeb/ -- Eiseman Construction is pleased to announce that owner Melissa Eiseman has joined the board of directors of the James A. Michener Art Museum .
  • Based in Doylestown, the Michener Museum showcases American art with a particular focus on Bucks County artists.
  • "The Michener Art Museum is a vital part of the cultural heritage of both Doylestown and Bucks County, and I am thrilled to join its board of directors," said Eiseman.
  • A longtime supporter of the beloved local museum, Eiseman previously served as chair of its Corporate Business Partner Advisory Board.

EQS-News: Wyden: Wyden Appoints Stuart Petersen to Lead Global Growth Expansion as Chief Revenue Officer

Retrieved on: 
Thursday, March 2, 2023

Wyden, the global leader in institutional trading technology for digital assets, announced today that Stuart Petersen is returning to its executive board as Chief Revenue Officer, effective immediately, to drive Wyden’s global expansion and future sales growth.

Key Points: 
  • Wyden, the global leader in institutional trading technology for digital assets, announced today that Stuart Petersen is returning to its executive board as Chief Revenue Officer, effective immediately, to drive Wyden’s global expansion and future sales growth.
  • Zurich (CH) – As Chief Revenue Officer, Petersen will be responsible for developing and executing Wyden’s global sales and regional go-to-market strategies, thus driving future revenue growth.
  • Stuart Petersen had previously been with Wyden for three years as Chief Revenue Officer and will be able to add immediate value as an expert on the company, the team, its solutions and target markets.
  • “Thanks to his long tenure at Wyden, Stuart enjoys full trust from the leadership team and has a very strong reputation among the entire Wyden team.

Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023

Retrieved on: 
Monday, February 20, 2023

Dr Mathias brings a wealth of experience in innovation, contract development and manufacturing to Oxford Biomedica

Key Points: 
  • Dr Mathias brings a wealth of experience in innovation, contract development and manufacturing to Oxford Biomedica
    Oxford, UK – 20 February 2023: Oxford, UK – Oxford Biomedica (LSE:OXB), a leading gene and cell therapy group, today announces that Dr Frank Mathias will officially join Oxford Biomedica as Chief Executive Officer (CEO) and Board member on Monday, 27th March 2023.
  • Dr Frank Mathias joins Oxford Biomedica from Rentschler Biopharma SE (“Rentschler”) where he has been CEO since 2016.
  • Dr Roch Doliveux, Chair and Interim CEO of Oxford Biomedica, said: “We are extremely excited about the imminent arrival of Frank as our new CEO.
  • Oxford Biomedica has a clear vision for the future, and I believe it has great potential to become the leader in the viral vector CDMO market.

ROOMDEX, a hotel upselling and merchandising innovator, appoints Stuart Dale to SVP Global Sales

Retrieved on: 
Thursday, February 2, 2023

BETHESDA, Md., Feb. 2, 2023 /PRNewswire-PRWeb/ -- ROOMDEX, the leading innovator in automated upselling solutions for hotels, today announced that Stuart Dale has joined the company as Senior Vice President of Global Sales. In his new position, Stuart will be responsible for leading the ROOMDEX team in maximizing growth and expanding reach across all regions.

Key Points: 
  • BETHESDA, Md., Feb. 2, 2023 /PRNewswire-PRWeb/ -- ROOMDEX , the leading innovator in automated upselling solutions for hotels, today announced that Stuart Dale has joined the company as Senior Vice President of Global Sales.
  • In his new position, Stuart will be responsible for leading the ROOMDEX team in maximizing growth and expanding reach across all regions.
  • At RateDock, Stuart played a pivotal role in launching the commercial proposition to the market and used his vast network to drive significant growth with customers and hotel partners.
  • Looking at the product pipeline, ROOMDEX promises to revolutionize hotel inventory merchandising and provide hotels with new ways to monetize their inventory."

Hotjar Welcomes Three New Executives to Support Next Phase of Global Expansion

Retrieved on: 
Wednesday, January 18, 2023

"I am extremely pleased to welcome Celine Maher, Mattia Santin and Marta Abalos to the Hotjar team," said Mohannad Ali, CEO of Hotjar.

Key Points: 
  • "I am extremely pleased to welcome Celine Maher, Mattia Santin and Marta Abalos to the Hotjar team," said Mohannad Ali, CEO of Hotjar.
  • Celine Maher joins Hotjar as the first Chief Revenue Officer and will lead the growth, expansion and success of Hotjar's customer base alongside the sales, customer success and support teams.
  • Most recently, Hotjar announced the acquisition of PingPong, officially renaming it to Hotjar Engage during the tail end of 2022.
  • As customers and the market evolves, Hotjar is gearing up to ensure customers can continue to empathize with their audience online.

EPCOR Announces President & Chief Executive Officer Succession

Retrieved on: 
Thursday, January 12, 2023

EDMONTON, AB, Jan. 12, 2023 /CNW/ - The Board of Directors of EPCOR Utilities Inc. ("EPCOR" or the "Company") announced today that Stuart Lee plans to retire as President and Chief Executive Officer at the completion of the Company's Annual General Meeting on May 2, 2023.

Key Points: 
  • EDMONTON, AB, Jan. 12, 2023 /CNW/ - The Board of Directors of EPCOR Utilities Inc. ("EPCOR" or the "Company") announced today that Stuart Lee plans to retire as President and Chief Executive Officer at the completion of the Company's Annual General Meeting on May 2, 2023.
  • Upon Mr. Lee's retirement, John Elford, currently EPCOR's Senior Vice President Commercial Services, will be appointed President and Chief Executive Officer.
  • "I am delighted to announce John Elford as our next CEO," said Janice Rennie, Chair of the EPCOR Board of Directors.
  • Mr. Elford joined EPCOR in 2004, and has been a member of the Company's senior executive team since 2015.